[go: up one dir, main page]

WO2009022399A1 - 胃液促進作用を有する新規微生物及びその分泌組成物 - Google Patents

胃液促進作用を有する新規微生物及びその分泌組成物 Download PDF

Info

Publication number
WO2009022399A1
WO2009022399A1 PCT/JP2007/065772 JP2007065772W WO2009022399A1 WO 2009022399 A1 WO2009022399 A1 WO 2009022399A1 JP 2007065772 W JP2007065772 W JP 2007065772W WO 2009022399 A1 WO2009022399 A1 WO 2009022399A1
Authority
WO
WIPO (PCT)
Prior art keywords
gastric juice
novel microorganism
microorganism
same
promoting action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2007/065772
Other languages
English (en)
French (fr)
Inventor
Yoshichika Kameyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/090,482 priority Critical patent/US8748158B2/en
Priority to EP07828165.6A priority patent/EP2196533B9/en
Priority to KR1020097005271A priority patent/KR101109985B1/ko
Priority to PCT/JP2007/065772 priority patent/WO2009022399A1/ja
Priority to JP2008524290A priority patent/JP4695191B2/ja
Publication of WO2009022399A1 publication Critical patent/WO2009022399A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

胃液の分泌を促進し、血小板増加作用を有する新規微生物及びその分泌物からなる医薬品の提供を目的とする。この新規微生物は、バチルス・プミルス（Ｂａｃｈｉｌｌｕｓ　ｐｕｍｉｌｕｓ）種に属する国際寄託番号NITE　BP－２９５で、球菌及び桿菌のいずれの形態もとりうることを特徴とし、８の字運動を行う。配列番号１の遺伝子を有する新規微生物であり、さらにはその微生物及びその微生物の分泌物からなる胃液分泌促進組成物の提供を目的とする。
PCT/JP2007/065772 2007-08-10 2007-08-10 胃液促進作用を有する新規微生物及びその分泌組成物 Ceased WO2009022399A1 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US12/090,482 US8748158B2 (en) 2007-08-10 2007-08-10 Microorganism having gastric-juice promoting activity, and its secretory product
EP07828165.6A EP2196533B9 (en) 2007-08-10 2007-08-10 Novel microorganism having gastric juice promoting action and composition secreted by the same
KR1020097005271A KR101109985B1 (ko) 2007-08-10 2007-08-10 위액촉진 작용을 갖는 신규 미생물 및 그 분비 조성물
PCT/JP2007/065772 WO2009022399A1 (ja) 2007-08-10 2007-08-10 胃液促進作用を有する新規微生物及びその分泌組成物
JP2008524290A JP4695191B2 (ja) 2007-08-10 2007-08-10 胃液促進作用を有する新規微生物及びその分泌組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2007/065772 WO2009022399A1 (ja) 2007-08-10 2007-08-10 胃液促進作用を有する新規微生物及びその分泌組成物

Publications (1)

Publication Number Publication Date
WO2009022399A1 true WO2009022399A1 (ja) 2009-02-19

Family

ID=40350463

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/065772 Ceased WO2009022399A1 (ja) 2007-08-10 2007-08-10 胃液促進作用を有する新規微生物及びその分泌組成物

Country Status (5)

Country Link
US (1) US8748158B2 (ja)
EP (1) EP2196533B9 (ja)
JP (1) JP4695191B2 (ja)
KR (1) KR101109985B1 (ja)
WO (1) WO2009022399A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102965299A (zh) * 2012-08-16 2013-03-13 天津农学院 短小芽孢杆菌LD-b1的发酵工艺及其在防治植物病害中的应用
CN103013887A (zh) * 2012-12-27 2013-04-03 昆明学院 一种短小芽孢杆菌kmxu56及其接种剂

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012201297A1 (de) 2012-01-31 2013-08-01 Basf Se Expressionsverfahren

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612352A (en) * 1979-07-11 1981-02-06 Asahi Chem Ind Co Ltd Ai-77, medically permissible salt thereof and their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058047B (en) * 1979-07-11 1983-09-21 Asahi Chemical Ind Amides and amidines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612352A (en) * 1979-07-11 1981-02-06 Asahi Chem Ind Co Ltd Ai-77, medically permissible salt thereof and their preparation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GenBank [o] 20 May 2005 (2005-05-20), PHAM, V. T. ET AL.: "Definition: Bacillus pumilus gene for 16s rRNA", Database accession no. AB195283 *
DUC, L H. ET AL.: "Characterization of Bacillus Probiotics Available for Human Use", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 70, no. 4, 2004, pages 2161 - 2171, XP003023953, DOI: doi:10.1128/AEM.70.4.2161-2171.2004 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102965299A (zh) * 2012-08-16 2013-03-13 天津农学院 短小芽孢杆菌LD-b1的发酵工艺及其在防治植物病害中的应用
CN103013887A (zh) * 2012-12-27 2013-04-03 昆明学院 一种短小芽孢杆菌kmxu56及其接种剂

Also Published As

Publication number Publication date
EP2196533A1 (en) 2010-06-16
EP2196533A4 (en) 2010-10-20
KR20090060415A (ko) 2009-06-12
EP2196533B1 (en) 2014-07-30
KR101109985B1 (ko) 2012-09-07
US20100291052A1 (en) 2010-11-18
US8748158B2 (en) 2014-06-10
JP4695191B2 (ja) 2011-06-08
EP2196533B9 (en) 2014-10-29
JPWO2009022399A1 (ja) 2010-11-11

Similar Documents

Publication Publication Date Title
WO2008153776A8 (en) Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using said compositions
NZ600540A (en) Ethanol production in non-recombinant hosts
WO2009011849A3 (en) Cartilage grafts
SE0402406L (sv) Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
WO2008073406A3 (en) Solvent tolerant microorganisms
WO2006092213A8 (de) Pyrazolylcarboxanilide
NZ597774A (en) Bacterial expression of an artificial gene for the production of cross reactive material 197 and its derivatives
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
UA100127C2 (ru) Пептид cdh3 и лекарственное средство, содержащее его
NZ594019A (en) Novel antibacterial agents for the treatment of gram positive infections
WO2008073853A8 (en) Lactobacillus buchneri strain ln5689 and its use to improve aerobic stability of silage
WO2008073839A3 (en) Lactobacillus buchneri strain ln1286 and its use to improve aerobic stability of silage
WO2006065137A3 (en) Novel efficient production process for capsular polysaccharides of pathogenic grampositive bacteria by heterologous expression and secretion of complex polysaccharides in non-pathogenic, non-invasive gram- positive bacteria
WO2009022399A1 (ja) 胃液促進作用を有する新規微生物及びその分泌組成物
NZ595364A (en) TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC beta-CELL DYSFUNCTION
TW200637860A (en) Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of same
MX2010010115A (es) Peptidos muy puenteados a partir de actinomadura namibiensis.
WO2010011990A3 (en) Isolation of novel bacteria contributing to soilborne disease suppression
MX2011008542A (es) Molecula de acido nucleico de un racimo biosintetico que codifica sintasas peptidicas no ribosomales y usos de la misma.
UA95630C2 (ru) Лизобактинамиды, способ их получения (варианты) и применение их как антибактериального средства
NZ589743A (en) Anxiolytic composition containing alphas1-casein-derived peptides
WO2007023342A3 (en) Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof
PL1838839T3 (pl) Bakterie kwasu mlekowego oporne na bakteriofagi
TW200640942A (en) New macrolides
EP1813289A4 (en) MEDICINAL COMPOSITION FOR THE TREATMENT OF CANCER OR DIABETES

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 12090482

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2008524290

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020097005271

Country of ref document: KR

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07828165

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2007828165

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE